← FDA DRUG APPROVALS
FDA ANDA · ANDA218273
CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE
Sponsor: COSETTE PHARMS NC
APPLICATION
ANDA218273
TYPE
ANDA
ORIGINAL APPROVAL
2025-11-10
LATEST ACTION
2025-11-10
ROUTE
AURICULAR (OTIC), OTIC
DOSAGE FORM
SUSPENSION/DROPS
MARKETING STATUS
Prescription
Products
CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONEPrescription
CIPROFLOXACIN HYDROCHLORIDE EQ 0.2% BASE, HYDROCORTISONE 1% · SUSPENSION/DROPS · OTIC
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.